“Making valid decisions: Learning from Patient Reported Outcomes.” – ISOQOL 2021

COS General news

ISOQOL 2021 took place in October, with online content available through end of November. Its theme – “Making valid decisions: Learning from Patient Reported Outcomes.” An intro to ISOQOL stated that “person-centred care is a fundamental shift in the delivery of health care that personalizes it by placing the patient/client at the nucleus of this care”.   At COS, we are committed to continuous, dedicated support …

Pride month – Coming out, is it much easier now than it was decades ago?

COS General news

In honor of Pride Month, two members of the Diversity and Inclusion Committee came together to discuss how coming out and being gay have changed since they came out.  Linda came out in the 1970’s, while Shehan came out in the early 2010’s.  They discussed what these changes have meant for them. The first change they noted is the representation …

Men’s Health Week 14 – 21 June

COS General news

June 14-20 is Men’s Health Week, and we are proud to be recognising the huge contributions our global team makes to the field of men’s health research. Our colleagues work tirelessly to further research, listening to the voices of those patients living with health issues that affect men disproportionately and ultimately allowing care pathways and treatments to be personalised, responsive, and …

June 6 is global National Cancer Survivors Day

COS General news

It is a sad fact that cancer has – and likely will – touch all of our lives in some way. June 6 is global National Cancer Survivors Day. Our colleagues work tirelessly to further #oncology research, listening to the voices of those patients living with #cancer and ultimately allowing care pathways and treatments to be personalised, responsive, and effective.Here …

New research: Lenvatinib vs sorafenib for first-line treatment of unresectable hepatocellular carcinoma: patient-reported outcomes from a phase 3 trial

COS General news

Our CEO, Stacie Hudgens, is co-author of a manuscript published by The Lancet on June 1: Lenvatinib versus sorafenib for first-line treatment of unresectable hepatocellular carcinoma: patient-reported outcomes from a randomised, open-label, non-inferiority, phase 3 trialHepatocellular carcinoma is the third-leading cause of cancer-related death worldwide. Preservation of health-related quality of life (HRQOL) during treatment is an important therapeutic goal. The …

Validant acquires Clinical Outcomes Solutions, a global leader in clinical outcomes assessment research services

COS General news

Adds complementary services in high growth sub-segment of HEOR Expands geographic presence with offices across the US and UK Validant, a leading global quality, compliance and regulatory consulting group, has acquired Clinical Outcomes Solutions (“COS”), a global leader in clinical outcomes assessments (COA). COS was founded in 2013 and has developed a leadership position in COA through its patient-centered approach …

Fibromyalgia awareness day

COS General news

12 May is Fibromyalgia awareness day, and we are proud to be recognising the huge contributions our global team makes to the field of patient research. Our colleagues recognise the need to further research, listen to the voices of those living with fibromyalgia and ultimately share knowledge on treatments. View relevant publications here:Li, Y., Morris, S., Cole, J., Dube, S., Smith, …

May is Skin Cancer Awareness Month

COS General news

May is Skin Cancer Awareness Month, and we are proud to be recognising the huge contributions our global team makes to the field of oncology research. Our colleagues work tirelessly to further research, listening to the voices of those patients living with skin cancer and ultimately allowing care pathways and treatments to be personalised, responsive, and effective. View relevant publications here:Wali, G. …

World Asthma Day 2021

COS General news

4 May is World Asthma Day, and we are proud to be recognising the huge contributions our global team makes to the field of asthma or chronic obstructive pulmonary disease (COPD) research. Our colleagues further research by listening to the voices of patients living with respiratory issues and ultimately allowing patients affected by respiratory conditions to feel that their condition is …

Clinical Outcomes Solutions and Carevive Systems Partner to Improve the Patient Experience in Cancer Care

COS General news

We are delighted to announce that Carevive has joined the Oncology Outcomes initiative to provide life science companies with analysis of cancer patient experience data for personalised drug development and improved patient care. As a global leader in the collection, analysis and reporting of patient-centred outcomes data, we are delighted to announce a collaborative partnership with Carevive Systems, the leading oncology-focused …